Ramineni, Aadhyasri
Faateh, Muhammad
Mehdizadeh-Shrifi, Amir
Hayes, Don Jr.
Morales, David L. S.
Article History
Received: 26 March 2024
Accepted: 11 June 2024
First Online: 6 July 2024
Declarations
:
: Morales is a consultant for Abbott Laboratories, Inc.; Azyio Biologics, Inc.; Berlin Heart, Inc.; CorMatrix Cardiovascular, Inc.; Peca Labs, Inc.; Syncardia Systems, LLC; and Xeltis, Inc.; and a principal investigator for FDA trials sponsored by Peca Labs, Inc. and Xeltis, Inc.
: The present study received institutional review board approval via waiver of informed consent (CCHMC IRB# 2018-6837).